Vasodilators in acute heart failure

Heart Failure Reviews

Volumn 12, Issue 2, 2007, Pages 143-147

  Hollenberg, Steven M ^a  

^a Department of Anesthesiology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; ENALAPRILAT; FUROSEMIDE; GLYCERYL TRINITRATE; ISOSORBIDE DINITRATE; LISINOPRIL; LOOP DIURETIC AGENT; MORPHINE; NESIRITIDE; NITRATE; NITROPRUSSIDE SODIUM; PLACEBO; SODIUM NITRITE; THIOSULFATE; VASODILATOR AGENT;

ACUTE HEART FAILURE; ACUTE HEART INFARCTION; ANGIONEUROTIC EDEMA; ARTICLE; ARTIFICIAL VENTILATION; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; CONTINUOUS INFUSION; COUGHING; CYANIDE POISONING; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG INDUCED HEADACHE; DRUG MEGADOSE; DRUG POTENTIATION; DRUG TOLERABILITY; HUMAN; HYPERKALEMIA; HYPOTENSION; KIDNEY DYSFUNCTION; KIDNEY FAILURE; LOADING DRUG DOSE; LOW DRUG DOSE; LUNG EDEMA; META ANALYSIS; OXYGEN SATURATION; SYSTEMATIC REVIEW; VASODILATATION;

ACUTE DISEASE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CLINICAL TRIALS; DIURETICS; DRUG THERAPY, COMBINATION; HEART FAILURE, CONGESTIVE; HUMANS; NATRIURETIC PEPTIDE, BRAIN; NITROGLYCERIN; NITROPRUSSIDE; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 34250357111     PISSN: 13824147     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10741-007-9017-2     Document Type: Article

References (23)

1. Felker GM, Adams KF Jr, Konstam MA, O'Connor CM, Gheorghiade M (2003) The problem of decompensated heart failure: Nomenclature, classification, and risk stratification. Am Heart J 145(2 Suppl):S18-S25
2. Adams KF Jr, Fonarow GC, Emerman CL et al (2005) Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 149:209-216
3. Cleland JG, Swedberg K, Follath F et al (2003) The EuroHeart Failure survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 1: Patient characteristics and diagnosis. Eur Heart J 24:442-463
4. Zannad F, Mebazaa A, Juilliere Y et al (2006) Clinical profile, contemporary management and one-year mortality in patients with severe acute heart failure syndromes: The EFICA study. Eur J Heart Fail 8(7):697-705
5. Teerlink JR (2005) Overview of randomized clinical trials in acute heart failure syndromes. Am J Cardiol 96(6A):59G-67G
6. Nohria A, Lewis E, Stevenson LW (2002) Medical management of advanced heart failure. JAMA 287(5):628-640
7. Dikshit K, Vyden JK, Forrester JS, Chatterjee K, Prakash R, Swan HJC (1973) Renal and extrarenal hemodynamic effects of furosemide in congestive heart failure after acute myocardial infarction. N Engl J Med 288:1087-1090
8. Cotter G, Metzkor E, Kaluski E et al (1998) Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema. Lancet 351:389-393
9. Cohn PF, Gorlin R (1974) Physiologic and clinical actions of nitroglycerin. Med Clin North Am 58:407-415
10. Elkayam U, Bitar F, Akhter MW, Khan S, Patrus S, Derakhshani M (2004) Intravenous nitroglycerin in the treatment of decompensated heart failure: Potential benefits and limitations. J Cardiovasc Pharmacol Ther 9(4):227-241
11. Flaherty JT, Becker LC, Bulkley BH et al (1983) A randomized trial of intravenous nitroglycerin in patients with acute myocardial infarction. Circulation 68:576-588
12. Munzel T, Daiber A, Mulsch A (2005) Explaining the phenomenon of nitrate tolerance. Circ Res 97(7):618-628
13. Elkayam U, Akhter MW, Singh H, Khan S, Usman A (2004) Comparison of effects on left ventricular filling pressure of intravenous nesiritide and high-dose nitroglycerin in patients with decompensated heart failure. Am J Cardiol 93(2):237-240
14. Cohn JN, Burke LP (1979) Nitroprusside. Ann Intern Med 91:752-757
15. Durrer JD, Lie KI, van Capelle FJ, Durrer D (1982) Effect of sodium nitroprusside on mortality in acute myocardial infarction. N Engl J Med 306(19):1121-1128
16. Cohn JN, Franciosa JA, Francis GS et al (1982) Effect of short-term infusion of sodium nitroprusside on mortality rate in acute myocardial infarction complicated by left ventricular failure: Results of a Veterans Administration cooperative study. N Engl J Med 306(19):1129-1135
17. Chiariello M, Gold HK, Leinbach RC, Davis MA, Maroko PR (1976) Comparison between the effects of nitroprusside and nitroglycerin on ischemic injury during acute myocardial infarction. Circulation 54:766-773
18. Colucci WS, Elkayam U, Horton DP et al (2000) Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide study group. N Engl J Med 343(4):246-253
19. VMAC Investigators (2002) Intravenous nesiritide vs. nitroglycerin for treatment of decompensated congestive heart failure: A randomized controlled trial. JAMA 287(12):1531-1540
20. Wang DJ, Dowling TC, Meadows D et al (2004) Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine. Circulation 110:1620-1625
21. Sackner-Bernstein JD, Skopicki HA, Aaronson KD (2005) Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure. Circulation 111:1487-1491
22. Sackner-Bernstein JD, Kowalski M, Fox M, Aaronson K (2005) Short-term risk of death after treatment with nesiritide for decompensated heart failure: A pooled analysis of randomized controlled trials. JAMA 293:1900-1905
23. Swedberg K, Held P, Kjekshus J et al (1992) Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II). New England Journal of Medicine 327:678-684